Key Insights

Highlights

Success Rate

77% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.6%

3 terminated out of 22 trials

Success Rate

76.9%

-9.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

30%

3 of 10 completed with results

Key Signals

3 with results77% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (11)
P 1 (1)
P 2 (3)

Trial Status

Completed10
Active Not Recruiting3
Terminated3
Not Yet Recruiting2
Unknown2
Enrolling By Invitation1

Trial Success Rate

76.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT03102229Not ApplicableCompleted

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

NCT04699188Phase 1Active Not Recruiting

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT05857995Not ApplicableRecruiting

Precision Lung Cancer Survivorship Care Intervention

NCT02549638Terminated

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

NCT05844761Not ApplicableEnrolling By InvitationPrimary

Real-time Motion Management During Prostate and Lung Radiotherapy

NCT06964503Not Yet RecruitingPrimary

Impact of Psychological Stress on Treatment Response and Prognosis in Lung Cancer Patients

NCT04263467Not ApplicableActive Not Recruiting

High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)

NCT04717804Not ApplicableCompletedPrimary

4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients

NCT04300244Phase 2Active Not Recruiting

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma

NCT06258954Not ApplicableNot Yet RecruitingPrimary

Effect of 3D-printed Reconstruction System in Size of Left DLT

NCT05011890Not ApplicableCompleted

Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®

NCT02673021Not ApplicableTerminated

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

NCT02931942Unknown

Changing Over Time of Ascorbic Acid After Chemotherapy

NCT01860898Not ApplicableCompleted

A Phase I Study of iPS Cell Generation From Patients With COPD

NCT02410603Completed

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT01470248Phase 2Completed

Study of Arsenic Trioxide in Small Cell Lung Cancer

NCT03603652Not ApplicableTerminatedPrimary

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

NCT03896958Unknown

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

NCT02616211Completed

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

NCT02853188Not ApplicableCompletedPrimary

Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung

Scroll to load more

Research Network

Activity Timeline